Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Monopar Therapeutics Inc. (MNPR) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Monopar Therapeutics Inc. (MNPR), most recent 12 months reported: net loss $17.84M. Latest balance sheet on file: liquid cash $134.3M. From SEC filings. Others in Pharmaceutical Preparations: MIRA Pharmaceuticals, Inc. · Milestone Pharmaceuticals Inc. · MOONLAKE IMMUNOTHERAPEUTICS · MINERALYS THERAPEUTICS, INC. · MapLight Therapeutics, Inc. · MATINAS BIOPHARMA HOLDINGS, INC. · METAVIA INC. · NovaBridge Biosciences

Stock screener

Watchlist